Biotherapeutics

Expanded Access for orBec^®

United States

There are currently no active expanded access programs for orBec^® in the US. Soligenix is currently working with its Medical Advisory Board to establish treatment protocols in appropriate applications (e.g., pediatric GI GVHD) and plans on initiating US expanded access programs in 2H2009.

For more information about expanded access in the US, please e-mail accessorbec@soligenix.com.